Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

333 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neurogenesis in the chronic lesions of multiple sclerosis.
Chang A, Smith MC, Yin X, Fox RJ, Staugaitis SM, Trapp BD. Chang A, et al. Among authors: fox rj. Brain. 2008 Sep;131(Pt 9):2366-75. doi: 10.1093/brain/awn157. Epub 2008 Jul 23. Brain. 2008. PMID: 18669500 Free PMC article.
Progressive multiple sclerosis.
Ontaneda D, Fox RJ. Ontaneda D, et al. Among authors: fox rj. Curr Opin Neurol. 2015 Jun;28(3):237-43. doi: 10.1097/WCO.0000000000000195. Curr Opin Neurol. 2015. PMID: 25887766 Free PMC article. Review.
The Future of Research in Multiple Sclerosis.
Fox RJ, Rudick RA. Fox RJ, et al. JAMA Neurol. 2015 Aug;72(8):853-4. doi: 10.1001/jamaneurol.2015.0270. JAMA Neurol. 2015. PMID: 26053218 No abstract available.
Relapses in multiple sclerosis: Relationship to disability.
Goodin DS, Reder AT, Bermel RA, Cutter GR, Fox RJ, John GR, Lublin FD, Lucchinetti CF, Miller AE, Pelletier D, Racke MK, Trapp BD, Vartanian T, Waubant E. Goodin DS, et al. Among authors: fox rj. Mult Scler Relat Disord. 2016 Mar;6:10-20. doi: 10.1016/j.msard.2015.09.002. Epub 2015 Sep 8. Mult Scler Relat Disord. 2016. PMID: 27063617 Review.
Imaging as an Outcome Measure in Multiple Sclerosis.
Ontaneda D, Fox RJ. Ontaneda D, et al. Among authors: fox rj. Neurotherapeutics. 2017 Jan;14(1):24-34. doi: 10.1007/s13311-016-0479-6. Neurotherapeutics. 2017. PMID: 27699722 Free PMC article. Review.
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.
Fox RJ, Coffey CS, Conwit R, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Naismith RT, Ashokkumar A, Barnes J, Ecklund D, Klingner E, Koepp M, Long JD, Natarajan S, Thornell B, Yankey J, Bermel RA, Debbins JP, Huang X, Jagodnik P, Lowe MJ, Nakamura K, Narayanan S, Sakaie KE, Thoomukuntla B, Zhou X, Krieger S, Alvarez E, Apperson M, Bashir K, Cohen BA, Coyle PK, Delgado S, Dewitt LD, Flores A, Giesser BS, Goldman MD, Jubelt B, Lava N, Lynch SG, Moses H, Ontaneda D, Perumal JS, Racke M, Repovic P, Riley CS, Severson C, Shinnar S, Suski V, Weinstock-Guttman B, Yadav V, Zabeti A; NN102/SPRINT-MS Trial Investigators. Fox RJ, et al. N Engl J Med. 2018 Aug 30;379(9):846-855. doi: 10.1056/NEJMoa1803583. N Engl J Med. 2018. PMID: 30157388 Free PMC article. Clinical Trial.
333 results